Literature DB >> 8829277

Ben Cassen and the development of the rectilinear scanner.

W H Blahd1.   

Abstract

The development of the rectilinear scanner by Benedict Cassen was preceded by his successful fabrication of a directional scintillation detector probe. In 1950, Cassen assembled the first automated scanning system that was comprised of a motor driven scintillation detector coupled to a relay printer. The scanner was used to image thyroid glands after the administration of radioiodine. Initial studies that were performed at the West Los Angeles Veterans Administration Medical Center led to the extensive use of the scanning system for thyroid imaging during the early 1950s. Cassen's development of the rectilinear scanner was a defining event in the evolution of clinical nuclear medicine. In 1956, Kuhl and his colleagues developed a photographic attachment for the Cassen scanner that improved its sensitivity and resolution. With the development of organ-specific radiopharmaceuticals, a commercial model of this system was widely used during the late 1950s until the early 1970s to scan the major body organs. The decline of the rectilinear photoscanner began in 1973 with the advent of computed axial tomography.

Entities:  

Mesh:

Year:  1996        PMID: 8829277     DOI: 10.1016/s0001-2998(96)80021-3

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  4 in total

Review 1.  Is there still a role for SPECT-CT in oncology in the PET-CT era?

Authors:  Rodney J Hicks; Michael S Hofman
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

2.  Let's embrace optical imaging: a growing branch on the clinical molecular imaging tree.

Authors:  Milou E Noltes; Gooitzen M van Dam; Wouter B Nagengast; Pieter J van der Zaag; Riemer H J A Slart; Wiktor Szymanski; Schelto Kruijff; Rudi A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12       Impact factor: 9.236

3.  Hybrid imaging is the future of molecular imaging.

Authors:  Rj Hicks; Ewf Lau; Ds Binns
Journal:  Biomed Imaging Interv J       Date:  2007-07-01

Review 4.  Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer.

Authors:  Kristin A Plichta; Stephen A Graves; John M Buatti
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.